Michelle Richner

17PUBLICATIONS
48CO-AUTHORS
Reaction engineering (excl. nuclear reactions)Innate immunityMedical molecular engineering of nucleic acids and proteinsMedical infection agents (incl. prions)Emergency medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 20, 2026
A pH-driven receptor switch from ACE2 to NPC1 enables endosomal entry of SARS-CoV-2.

Yong-Hui Zheng, Zhongshun Liu, Yu Pang

|Jan 16, 2026
Persistent Immune Dysregulation during Long COVID is Manifested in Antibodies Targeting Envelope and Nucleocapsid Proteins.

Marcin Kwissa, Manikannan Mathayan, Satyajeet S Salunkhe

|Jan 14, 2026
N1-Methylpseudouridine directly modulates translation dynamics.

Batsheva Rozman, Karin Broennimann, K Shanmugha Rajan

|Dec 03, 2025
mRNA-LNP Vaccines Encoding for Dengue Optimized prM/ENV Proteins Induce Protective Immunity without ADE.

Enzo LaMontia-Hankin, Clayton J Wollner, E Taylor Stone

|Nov 18, 2025
Therapeutic targeting of endothelial calcium signaling accelerates the resolution of lung injury.

Wan Ching Chan, Man Long Kwok, Xinyan Qu

|Oct 29, 2025
SARS-CoV-2 Infection Influences Wnt/β-Catenin Pathway Components in Astrocytes.

KaReisha F Robinson, Avantika I Ahiya, Justin M Richner

Pageof 3